Virtu Financial LLC Purchases Shares of 18,905 KORU Medical Systems, Inc. (NASDAQ:KRMD)

Virtu Financial LLC acquired a new stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 18,905 shares of the company’s stock, valued at approximately $73,000.

Several other institutional investors and hedge funds have also recently modified their holdings of KRMD. HighTower Advisors LLC boosted its holdings in shares of KORU Medical Systems by 13.0% during the 4th quarter. HighTower Advisors LLC now owns 43,400 shares of the company’s stock worth $167,000 after buying an additional 5,000 shares during the period. XTX Topco Ltd bought a new stake in shares of KORU Medical Systems during the third quarter worth approximately $34,000. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of KORU Medical Systems by 77.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after acquiring an additional 26,860 shares during the period. Y Intercept Hong Kong Ltd bought a new position in shares of KORU Medical Systems during the fourth quarter worth approximately $104,000. Finally, Geode Capital Management LLC increased its stake in shares of KORU Medical Systems by 6.5% during the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after purchasing an additional 28,323 shares during the period. 58.60% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have commented on KRMD shares. Craig Hallum upped their price objective on KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a report on Friday, January 17th. B. Riley upgraded shares of KORU Medical Systems to a “strong-buy” rating in a research note on Thursday, March 13th. Piper Sandler reiterated a “neutral” rating and issued a $4.50 price objective on shares of KORU Medical Systems in a research note on Friday, February 14th. Finally, Lake Street Capital increased their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $4.70.

KORU Medical Systems Stock Down 1.9 %

Shares of NASDAQ KRMD opened at $2.54 on Tuesday. The stock has a market capitalization of $116.73 million, a P/E ratio of -10.16 and a beta of 0.74. The stock’s fifty day moving average is $3.67 and its 200 day moving average is $3.43. KORU Medical Systems, Inc. has a 52 week low of $2.05 and a 52 week high of $5.05. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.